The use of AI to aid diagnosis has been heralded increasingly often as an imminent evolution in the world of gastroenterology (1, 2). Thanks to an Italian study, in April the FDA has approved for the first time a tool for colonoscopy that helps doctors detect suspicious lesions in real time whilst performing the examination (3, 4).
The Corpus Content Team
Owing to social restrictions still in place in the continued effort to halt the COVID-19 pandemic, the next ESMO Breast Cancer Congress 2021 (5-8 May 2021) is due to take place in a fully virtual environment.
Heart failure (HF) is a pressing and illusive public health epidemic. Nearly 50% of all HF cases involve HFpEF — to which there is no defined therapy (1). As such, refining prediction and treatment of HF is a crucial step in alleviating high morbidity and mortality (2). The development of novel clinical tools and therapies that assist in the diagnosis and management of HF, such as the use of biomarkers, are essential to improving patient outcomes.
A year has passed since The Corpus closed its offices due to the pandemic and the Prime Minister asked us all to work from home ‘for a few weeks’. Three national lockdowns later and the team has now been working from home for an entire year – a long time to be apart by anyone’s standards.
So, to mark this strange anniversary, we asked everyone at The Corpus what they have been up to over the past 12 months and what they have learned.
Migraine, whether episodic or chronic, is a complex condition characterised by a wide spectrum of symptoms – from hypersensitivity, nausea and sickness to visual disturbances, loss of concentration and vertigo.
Vaccination is one of the most effective investments in global health: WHO reports that vaccines save 2–3 million lives each year, with a considerable potential for growth should worldwide coverage improve.
There is no doubt that 2020 presented us all with new challenges. With many countries introducing nationwide lockdowns and restricting travel, face-to-face meetings were postponed, delayed or cancelled. With the emergence of a global health crisis, it became increasingly important to find ways to ensure healthcare professionals stayed connected. As a result, more people were looking to online solutions, and The Corpus team have been happy to offer our expertise.
The incidence of chronic kidney disease (CKD) is consistently increasing, particularly in Asia and North America, as lifestyle-related conditions such as elevated blood pressure and type 2 diabetes are two key drivers. Almost 900 million people globally suffer from this condition, of whom approximately 4 million are on dialysis.1 In addition, CKD is associated with an important increase in the risk of cardiovascular complications, as well as cardiovascular and overall mortality (up to 12-fold!) compared with the general population.2,3
As highlighted in our previous blog post from the European CME Conference, virtual meetings are here to stay. Although there has been some talk of ‘zoom fatigue’ in the past few weeks, recent surveys of healthcare professionals (HCPs) has highlighted a continued enthusiasm for online meetings if done right. Further evidence is rolling in from successful virtual medical congresses held throughout 2020, reinforcing the benefits of well-planned digital events.
Most people would argue that there’s no substitute to meeting face to face, and for good reason. Communication is about more than words — tone and body language are key, and this can often get lost outside of face-to-face conversations. However, it’s not always possible or practical to be physically present for every discussion, whether due to restrictions on travel (thanks to Covid-19 or otherwise) or for reasons of cost or convenience.